Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1970 8
1971 32
1972 37
1973 26
1974 31
1975 39
1976 28
1977 23
1978 38
1979 28
1980 44
1981 55
1982 76
1983 74
1984 99
1985 102
1986 81
1987 92
1988 54
1989 60
1990 50
1991 52
1992 55
1993 43
1994 37
1995 48
1996 38
1997 45
1998 38
1999 34
2000 32
2001 45
2002 60
2003 100
2004 103
2005 109
2006 115
2007 121
2008 108
2009 124
2010 139
2011 142
2012 142
2013 120
2014 132
2015 130
2016 134
2017 125
2018 136
2019 126
2020 139
2021 127
2022 90
2023 76
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

3,843 results

Results by year

Filters applied: . Clear all
Page 1
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions.
Preti M, Joura E, Vieira-Baptista P, Van Beurden M, Bevilacqua F, Bleeker MCG, Bornstein J, Carcopino X, Chargari C, Cruickshank ME, Erzeneoglu BE, Gallio N, Heller D, Kesic V, Reich O, Stockdale CK, Temiz BE, Woelber L, Planchamp F, Zodzika J, Querleu D, Gultekin M. Preti M, et al. J Low Genit Tract Dis. 2022 Jul 1;26(3):229-244. doi: 10.1097/LGT.0000000000000683. Epub 2022 Jun 21. J Low Genit Tract Dis. 2022. PMID: 35763611 Free PMC article.
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) developed consensus statements on …
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the …
Interleukin-18.
Dinarello CA. Dinarello CA. Methods. 1999 Sep;19(1):121-32. doi: 10.1006/meth.1999.0837. Methods. 1999. PMID: 10525448 Review.
This short review summarizes the present knowledge on IL-18, to give an insight into the future perspectives for its possible use as vaccine adjuvant. Formerly called interferon (IFN) gamma inducing factor (IGIF), IL-18 is the new name of a novel cytokine that plays an imp …
This short review summarizes the present knowledge on IL-18, to give an insight into the future perspectives for its possible use as vaccine …
Actinic keratoses.
Stockfleth E. Stockfleth E. Cancer Treat Res. 2009;146:227-39. doi: 10.1007/978-0-387-78574-5_20. Cancer Treat Res. 2009. PMID: 19415207 Review. No abstract available.
Interferon review.
Stanton GJ, Weigent DA, Fleischmann WR Jr, Dianzani F, Baron S. Stanton GJ, et al. Invest Radiol. 1987 Mar;22(3):259-73. doi: 10.1097/00004424-198703000-00017. Invest Radiol. 1987. PMID: 2435674 Review.
Tumor immunology and interferon.
Feinerman B. Feinerman B. South Med J. 1978 Nov;71(11):1409-11. doi: 10.1097/00007611-197811000-00027. South Med J. 1978. PMID: 362539 Review.
One of the important lymphokines produced by T-lymphocytes is called interferon, well known for its antiviral effects. Recent experimental evidence points also to the potential effectiveness of interferon against malignancies. Interferon and interferon …
One of the important lymphokines produced by T-lymphocytes is called interferon, well known for its antiviral effects. Recent experim …
Viral interference and interferon.
Dianzani F. Dianzani F. Ric Clin Lab. 1975 Jul-Sep;5(3):196-213. doi: 10.1007/BF02908284. Ric Clin Lab. 1975. PMID: 778995 Review.
The interferon produced by a cell can migrate to other cells not yet involved by the spreading infection, transmitting to them the antiviral-resistant state. ...This problem can be approached also by administering exogenous interferon. Encouraging preliminary result …
The interferon produced by a cell can migrate to other cells not yet involved by the spreading infection, transmitting to them the an …
Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer.
Gomez S, Cox OL, Walker RR 3rd, Rentia U, Hadley M, Arthofer E, Diab N, Grundy EE, Kanholm T, McDonald JI, Kobyra J, Palmer E, Noonepalle S, Villagra A, Leitenberg D, Bollard CM, Saunthararajah Y, Chiappinelli KB. Gomez S, et al. J Immunother Cancer. 2022 Nov;10(11):e004974. doi: 10.1136/jitc-2022-004974. J Immunother Cancer. 2022. PMID: 36343976 Free PMC article.
These dsRNAs activate sensors in the cytoplasm and trigger type I interferon (IFN) signaling, recruiting host immune cells to kill the tumor cells. ...Mice were injected with syngeneic shAdar1 ID8 Trp53(-/-) cells and treated with tetrahydrouridine/DNMTi while given anti- …
These dsRNAs activate sensors in the cytoplasm and trigger type I interferon (IFN) signaling, recruiting host immune cells to kill th …
Interferon--present and future prospects.
Richtsmeier WJ. Richtsmeier WJ. Crit Rev Clin Lab Sci. 1984;20(1):57-93. doi: 10.3109/10408368409165770. Crit Rev Clin Lab Sci. 1984. PMID: 6202461 Review.
The offshot of the technology developed to study the intracellular processes after interferon treatment have already led to increased sensitivity to detect virally treated diseases. Both the variety of the interferon inducers and the scope of parasites in whi …
The offshot of the technology developed to study the intracellular processes after interferon treatment have already led to increased …
Imiquimod.
Garland SM. Garland SM. Curr Opin Infect Dis. 2003 Apr;16(2):85-9. doi: 10.1097/00001432-200304000-00004. Curr Opin Infect Dis. 2003. PMID: 12734440 Review.
Tumor inherent interferons: Impact on immune reactivity and immunotherapy.
Brockwell NK, Parker BS. Brockwell NK, et al. Cytokine. 2019 Jun;118:42-47. doi: 10.1016/j.cyto.2018.04.006. Epub 2018 Apr 19. Cytokine. 2019. PMID: 29681426 Review.
In support of a link between IFN signaling and immunotherapeutic response, the combination of type I interferon inducers with checkpoint immunotherapy has recently been demonstrated critical for a sustained anti-tumor response in aggressive breast cancer models. Her …
In support of a link between IFN signaling and immunotherapeutic response, the combination of type I interferon inducers with …
3,843 results